The commerce ministry's investigation arm Directorate General of Trade Remedies (DGTR) has recommended anti-dumping duty of up to $20.87 per kilogram on import of a certain kind of vitamin, used for animal consumption, from China, the European Union (EU) and Switzerland for five years. The DGTR in its findings has concluded that imports of 'Vitamin A Palmitate' have significantly increased in absolute terms.
Due to the dumping, the performance of domestic industry in terms of profit, cash profits and ROCE (Return on Capital Employed) has been adversely affected. The authority recommends imposition of anti-dumping duty on the imports for a period of five years. The recommended duty ranges between $0.87-20.87 per kg. The finance ministry will take the final decision to impose the duty. Piramal Pharma had filed a petition before the DGTR for imposition of the duty on the imports.
In a separate notification, the DGTR has also recommended anti-dumping duty of up to $358 per tonne on 'Insoluble Sulphur' exported from China and Japan for five years. The chemical is widely used in the manufacture of tyre, shoes, and all kinds of automobile rubber parts.
Anti-dumping probes are conducted by countries to determine whether domestic industries have been hurt because of a surge in cheap imports. As a counter measure, they impose these duties under the multilateral regime of the Geneva-based World Trade Organization (WTO). The duty is aimed at ensuring fair trading practices and creating a level-playing field for domestic producers vis-a-vis foreign producers and exporters. India has already imposed anti-dumping duty on several products to tackle cheap imports from various countries, including China.
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: